CCNU样本体内抗P388白血病活性变异性的原因。 - Suppr | 超能文献

Cause of variability in activity of samples of CCNU against P388 leukemia in vivo.

作者信息

Montgomery J A

出版信息

Cancer Treat Rep. 1980 Aug-Sep;64(8-9):987-91.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cause of variability in activity of samples of CCNU against P388 leukemia in vivo.CCNU样本体内抗P388白血病活性变异性的原因。

Cancer Treat Rep. 1980 Aug-Sep;64(8-9):987-91.

2

Synergistic antileukemic activity of combinations of two nitrosoureas.两种亚硝基脲组合的协同抗白血病活性。

Cancer Treat Rep. 1981 Jul-Aug;65(7-8):591-9.

3

Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy.用于实验性脑肿瘤化疗的环己亚硝脲瘤内注射

Surg Neurol. 1977 Feb;7(2):73-7.

4

Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.体内P388白血病模型在天然产物抗肿瘤活性评估中的稳定性。

Cancer Treat Rep. 1985 Jun;69(6):683-5.

5

Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.对携带P388或L1210白血病的小鼠口服蒽环类药物7-氧甲基诺加罗（7-OMEN）的活性。

Cancer Treat Rep. 1980 Apr-May;64(4-5):727-9.

6

Evaluation of Mannich bases of styryl ketones and related hydrazones for activity against P388 leukemia.对苯乙烯基酮的曼尼希碱及相关腙对P388白血病活性的评估。

Neoplasma. 1988;35(6):715-24.

7

Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.在小鼠肿瘤系统中，角鲨烯对3-[(4-氨基-2-甲基-5-嘧啶基)甲基]-1-(2-氯乙基)-亚硝基脲抗肿瘤作用的增强作用。

Jpn J Cancer Res. 1985 Oct;76(10):1021-6.

8

Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.新型化疗药物BBM 928A的实验性抗肿瘤活性与毒性

Cancer Res. 1983 Apr;43(4):1504-10.

9

Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia.使用P388白血病细胞的体外肿瘤干细胞检测与体内抗肿瘤活性之间的关系。

Int J Cell Cloning. 1988 Jan;6(1):60-8. doi: 10.1002/stem.5530060107.

10

[Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].1-（2-氯乙基）-3-环己基-1-亚硝基脲（CCNU）与环磷酰胺（CPA）以及甲基CCNU与CPA联合用于移植大鼠白血病L 5222的化疗（作者译）

Arzneimittelforschung. 1981;31(2):303-5.